• Donate
  • Contact
Canadian Association of Pompe
  • Home
  • About Us
    • Portraits of Pompe
    • Our Partners
    • Newsletter
  • About Pompe
    • Webinars
  • Blog
  • Links
  • Connections
Select Page
Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints

Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints

by CAP | Dec 13, 2007 | Press Releases

Recent Posts

  • New Review Article Highlights Latest Developments in Pompe Disease Research
  • The Genetic Non-Discrimination Act
  • New ERT For Late-onset Pompe Disease Shows Promise
  • 2020 CAP Annual General Meeting
  • John
  • Terms
  • Privacy

Copyright © 2006 - 2020 Canadian Association of Pompe | Developed by PacificByte

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok